Sarepta Therapeutics, Inc.
Sarepta Therapeutics, Inc. (SRPT) is a publicly traded company in the Unknown sector. Across all available filings, 35 corporate insiders have executed 558 transactions totaling $205.6M, demonstrating a bearish sentiment with -$111.0M in net insider flow. The most recent transaction on Jan 29, 2026 involved a transaction of 10,500 shares valued at $0.
SRPT Insider Activity Summary
Who Is Buying SRPT Stock?
No significant insider buying has been recorded for SRPT in the recent period.
Who Is Selling SRPT Stock?
No significant insider selling has been recorded for SRPT in the recent period.
Is Sarepta Therapeutics, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for SRPT is bearish with an Insider Alignment Score of 23/100 and a net flow of -$111.0M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
SRPT Frequently Asked Questions
Understanding SRPT Insider Activity
Insider trading at Sarepta Therapeutics, Inc. (SRPT) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 35 insiders are actively trading SRPT stock, having executed 558 transactions in the past 90 days. The most active insider is Sandesh Mahatme (Executive), who has made 67 transactions totaling $71.2M.
Related Tools
Track Sarepta Therapeutics, Inc. Insider Activity
Get notified when executives and directors at SRPT file new Form 4 transactions